checkAd

     383  0 Kommentare Pasithea Therapeutics to Call Special Meeting of Stockholders - Seite 3

    Pasithea Therapeutics Corp. Company Contact

    Dr. Tiago Reis Marques
    Chief Executive Officer
    E: tiago@pasithea.com

    Michael Fein
    Kingsdale Advisors
    T: 646-651-1641
    E: mfein@kingsdaleadvisors.com

    Pasithea Therapeutics Corp. Media Contact

    Paul Caminiti/Nicholas Leasure
    Reevemark
    T: 212-433-4600
    E: PasitheaTeam@reevemark.com

    Pasithea Therapeutics Corp. Investor Relations

    Lisa M. Wilson
    In-Site Communications, Inc.
    T: 212-452-2793
    E: lwilson@insitecony.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Pasithea Therapeutics to Call Special Meeting of Stockholders - Seite 3 No action required by stockholdersMIAMI BEACH, Fla., Oct. 03, 2022 (GLOBE NEWSWIRE) - Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of new and …